Cullinan Oncology (CGEM) PEG Ratio

Price: $7.405
Market Cap: $433.29M
Avg Volume: 450.11K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: -0.114
52W Range: $7.3-30.189
Website: Cullinan Oncology

PEG Ratio Summary

  • Cullinan Oncology's trailing twelve month (TTM) PEG ratio is 0.30.
  • Cullinan Oncology's annual PEG ratio as of today is 0.00.
  • Cullinan Oncology's quarterly PEG ratio is -0.24.

What is the PEG Ratio?

The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.

How is the PEG Ratio calculated?

The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:

PEG Ratio = (P/E Ratio) / (EPS Growth Rate)

This helps investors to determine a stock's value while considering the company's earnings growth.

Related Metrics

Other important metrics to assess Cullinan Oncology's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: 0.00
    • Quarterly: -3.74
    • TTM: -2.59
  • P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
    • Annual: 0.00
    • Quarterly: 0.00
    • TTM: 0.00
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 0.00
    • Quarterly: 1.21
    • TTM: 0.73
  • P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: 0.00
    • Quarterly: -19.48
    • TTM: -2.99

These metrics provide insights into Cullinan Oncology's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

TTM PEG Ratio

0.30

Annual PEG Ratio

0.00

Quarterly PEG Ratio

-0.24

Cullinan Oncology Historical PEG Ratio

1.361.360.770.770.180.18-0.41-0.41PEG Ratio0.000.01-0.02-0.41-0.171.030.0020192019202020202021202120222022202320232024202420252025

Historical P/E Ratio

20.0020.000.000.00-20.00-20.00-40.00-40.00-60.00-60.00-80.00-80.00P/E Ratio0.00-2.764.28-10.51-25.60-64.96-24.1420192019202020202021202120222022202320232024202420252025

Historical P/S Ratio

45.0045.0036.0036.0027.0027.0018.0018.009.009.000.000.00P/S Ratio0.000.000.0036.080.000.000.0020192019202020202021202120222022202320232024202420252025

Historical P/B Ratio

8.008.000.000.00-8.00-8.00-16.00-16.00-24.00-24.00-32.00-32.00P/B Ratio0.000.930.891.62-16.76-31.92-16.5820192019202020202021202120222022202320232024202420252025

Historical P/CF Ratio

0.000.00-20.00-20.00-40.00-40.00-60.00-60.00-80.00-80.00P/CF Ratio0.00-3.15-3.76-15.74-43.72-62.28-25.2820192019202020202021202120222022202320232024202420252025

Cullinan Oncology Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year PEG Ratio P/E Ratio P/S Ratio P/B Ratio P/CF Ratio
2024 0.00 0.00 0.00 0.00 0.00
2023 0.01 -2.76 0.00 0.93 -3.15
2022 -0.02 4.28 0.00 0.89 -3.76
2021 -0.41 -10.51 36.08 1.62 -15.74
2020 -0.17 -25.60 0.00 -16.76 -43.72
2019 1.03 -64.96 0.00 -31.92 -62.28
2018 0.00 -24.14 0.00 -16.58 -25.28

Related Metrics

Explore detailed financial metrics and analysis for CGEM.